Title: Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV Infection: The REALM Study. Clinical Protocol AI463080
Sponsor: Bristol-Myers Squibb Research and Development, Wallingford, USA
Principal investigator: Prof. MUDr. Pavel Chalupa, CSc.
Co-investigators: Doc. MUDr. Michal Holub, Ph.D., Zuzana Janštová
Since: 2008

Title: A Randomized, Double-Blind, single dose, One-Day Early Administration, Multicentre Study comparing the Efficacy and Safety of Acyclovir lauriad 50 mg muco-adhesive buccal tablet to matching Placebo, in the Treatment of Herpes Labialis in immunocompetent patients
Sponsor: BioAliance Pharma
Principal investigator: MUDr. Viktor Aster
Co-investigators: 0
Since: 2007